Comparison of the effects of several inhibitors of the synthesis of nucleic acids upon the viability and progression through the cell cycle of cultured H. Ep. no. 2 cells.
D000963:Antimetabolites / Q000008:administration & dosage / Q000494:pharmacology*; D001375:Azaguanine / Q000494:pharmacology; D002277:Carcinoma / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D002470:Cell Survival; D003561:Cytarabine / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005467:Floxuridine / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects; D012263:Ribonucleosides / Q000494:pharmacology; D013866:Thioguanine / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium
D000963:Antimetabolites; D012263:Ribonucleosides; D005467:Floxuridine; D003561:Cytarabine; D014316:Tritium; D015122:Mercaptopurine; D013866:Thioguanine; D001375:Azaguanine; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate